Evidence map›Paper›PMID 42317898›Full record

ArticleCureus2026

Primary Hyperparathyroidism Due to Parathyroid Adenoma in a Post-Kidney Transplant Patient With Lupus Nephritis: A Case Report.

Hamza Mehmood, Maurice Maglasang, Sepehr Seifi, Charles Wood, Donnie Aultman

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hamza MehmoodGeneral Surgery, Edward Via College of Osteopathic Medicine, Monroe, USA.
Maurice MaglasangOsteopathic Medicine, New York Institute of Technology College of Osteopathic Medicine at Arkansas State University, Jonesboro, USA.
Sepehr SeifiMedicine, Arkansas College of Osteopathic Medicine, Fort Smith, USA.
Charles WoodOsteopathic Medicine, New York Institute of Technology College of Osteopathic Medicine at Arkansas State University, Jonesboro, USA.
Donnie AultmanTransplant Surgery, Willis Knighton Health System, Shreveport, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperparathyroidism is common in patients with existing chronic kidney disease (CKD), typically manifesting as secondary or tertiary hyperparathyroidism. We report a 47-year-old African American woman who initially presented with CKD secondary to lupus nephritis, as well as hyperparathyroidism, thought to be secondary to worsening kidney function. Following a kidney transplant, parathyroid hormone (PTH) was persistently elevated, at levels ranging from 370.4 to 614.9 pg/mL (reference range: 10-65 pg/mL) over the course of 12 months. Uptake on nuclear imaging demonstrated retained radionuclide along the posterior left thyroid lobe, which raised the suspicion for a diagnosis of primary hyperparathyroidism due to a parathyroid adenoma. The need for surgical intervention was supported, with the evidence obtained, and the patient was therefore treated with left inferior parathyroidectomy and has since had no complaints. This case highlights the importance of considering single-gland adenomatous pathology in post-transplant patients with persistent hyperparathyroidism, contrasted with multiple-gland hyperplasia seen in autonomous tertiary hyperparathyroidism, as expected in the usual circumstance.

Indexed as

hyperparathyroidismparathyroid adenomaparathyroidectomypost-transplant hypercalcemiarenal transplantation

Identifiers

PMID42317898
PMCPMC13274405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.